Kailera Therapeutics, Inc. (KLRA)
Nasdaq: KLRA · Pharmaceutical Preparations · filing with the SEC since 2025
Who owns Kailera Therapeutics, Inc.
As filed with the SECHolders of 5% or more
5
BCPE Perseus Investor, LP holds 20.3% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13D filed Apr 23, 2026 says.
Directors and officers
16
report now, of 16 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
BCPE Perseus Investor, LP
SCHEDULE 13D · filed Apr 23, 2026 · Common Stock, $0.00001 par value per share
BCLS Fund IV Investments, L.P.
SCHEDULE 13D · filed Apr 23, 2026 · Common Stock, $0.00001 par value per share
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
SCHEDULE 13G · filed Aug 5, 2026 · Common Stock, $0.00001 par value per share
RTW Investments, LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.00001 par value
CPP Investment Board Private Holdings (4) Inc.
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.00001 par value per share
What KLRA reports owning in othersstakes of 5% or more, and other ties
Kailera Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$159Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Kaplan Andrew T. | director | 0 | $0 | 0 | 1 | $134M |
| Koppel Adam | director | 0 | $0 | 0 | 1 | $25.0M |
| Rtw Investments, LP | 10% owner | 0 | $0 | 0 | 1 | $8.0M |
| Bcls Fund IV Investments Gp, LLC | 10% owner | 0 | $0 | 0 | 1 | $25.0M |
| Bcpe Perseus Investor, LP | 10% owner | 0 | $0 | 0 | 1 | $134M |